Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 63 | 2024 | 17530 | 1.900 |
Why?
|
Pregnancy Complications, Infectious | 22 | 2024 | 2184 | 1.820 |
Why?
|
Anti-HIV Agents | 19 | 2024 | 4558 | 1.100 |
Why?
|
Anti-Retroviral Agents | 8 | 2024 | 1786 | 0.930 |
Why?
|
Condoms | 3 | 2013 | 336 | 0.780 |
Why?
|
Contraceptive Devices, Female | 5 | 2012 | 39 | 0.720 |
Why?
|
Infectious Disease Transmission, Vertical | 17 | 2024 | 1353 | 0.720 |
Why?
|
Viral Load | 10 | 2021 | 3385 | 0.690 |
Why?
|
Antiretroviral Therapy, Highly Active | 6 | 2018 | 1899 | 0.680 |
Why?
|
Maternal-Fetal Exchange | 2 | 2019 | 453 | 0.670 |
Why?
|
Sexual Partners | 3 | 2013 | 804 | 0.640 |
Why?
|
Prisoners | 6 | 2007 | 315 | 0.610 |
Why?
|
Medication Adherence | 6 | 2021 | 2190 | 0.570 |
Why?
|
Acquired Immunodeficiency Syndrome | 5 | 2024 | 2204 | 0.540 |
Why?
|
Premature Birth | 8 | 2023 | 1829 | 0.530 |
Why?
|
HIV Protease Inhibitors | 4 | 2022 | 430 | 0.520 |
Why?
|
Domestic Violence | 2 | 2016 | 180 | 0.500 |
Why?
|
Child Development | 5 | 2020 | 2327 | 0.430 |
Why?
|
Pregnancy | 38 | 2024 | 30215 | 0.420 |
Why?
|
Treatment Failure | 1 | 2019 | 2655 | 0.420 |
Why?
|
Diaphragm | 2 | 2013 | 356 | 0.410 |
Why?
|
Sex Offenses | 1 | 2016 | 356 | 0.380 |
Why?
|
Crime Victims | 1 | 2016 | 347 | 0.380 |
Why?
|
Incest | 1 | 2010 | 19 | 0.350 |
Why?
|
Sexual Behavior | 7 | 2013 | 2192 | 0.340 |
Why?
|
Postpartum Period | 5 | 2024 | 1196 | 0.330 |
Why?
|
Rape | 1 | 2010 | 131 | 0.320 |
Why?
|
Patient Compliance | 4 | 2011 | 2693 | 0.280 |
Why?
|
Adolescent | 38 | 2024 | 88794 | 0.280 |
Why?
|
Financing, Government | 1 | 2010 | 473 | 0.270 |
Why?
|
AIDS Serodiagnosis | 1 | 2007 | 220 | 0.250 |
Why?
|
Young Adult | 28 | 2024 | 59849 | 0.250 |
Why?
|
Reverse Transcriptase Inhibitors | 3 | 2022 | 618 | 0.240 |
Why?
|
Marijuana Smoking | 2 | 2021 | 260 | 0.240 |
Why?
|
Substance-Related Disorders | 6 | 2024 | 4416 | 0.240 |
Why?
|
Caregivers | 2 | 2019 | 2304 | 0.230 |
Why?
|
Patient Acceptance of Health Care | 3 | 2016 | 3229 | 0.230 |
Why?
|
Sexually Transmitted Diseases | 5 | 2022 | 667 | 0.230 |
Why?
|
Meconium | 2 | 2015 | 47 | 0.230 |
Why?
|
Abortion, Induced | 1 | 2010 | 471 | 0.230 |
Why?
|
Ambulatory Care Facilities | 1 | 2010 | 937 | 0.220 |
Why?
|
Prisons | 1 | 2006 | 178 | 0.220 |
Why?
|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2024 | 39 | 0.220 |
Why?
|
Female | 61 | 2024 | 396050 | 0.220 |
Why?
|
Mental Disorders | 4 | 2019 | 6872 | 0.220 |
Why?
|
United States | 26 | 2024 | 72896 | 0.210 |
Why?
|
Trichomonas Infections | 1 | 2022 | 41 | 0.200 |
Why?
|
HIV-1 | 6 | 2022 | 6943 | 0.200 |
Why?
|
Cohort Studies | 20 | 2024 | 41643 | 0.200 |
Why?
|
Trichomonas vaginalis | 1 | 2022 | 70 | 0.200 |
Why?
|
Zidovudine | 2 | 2021 | 626 | 0.180 |
Why?
|
Infant, Newborn | 14 | 2023 | 26337 | 0.180 |
Why?
|
Mitochondrial Diseases | 1 | 2024 | 344 | 0.180 |
Why?
|
Adult | 40 | 2024 | 223055 | 0.180 |
Why?
|
Child | 22 | 2024 | 80509 | 0.180 |
Why?
|
Hair | 2 | 2021 | 508 | 0.170 |
Why?
|
Longitudinal Studies | 9 | 2023 | 14745 | 0.170 |
Why?
|
Oxazines | 1 | 2022 | 358 | 0.170 |
Why?
|
Vaginal Creams, Foams, and Jellies | 2 | 2011 | 62 | 0.170 |
Why?
|
Syphilis | 1 | 2022 | 243 | 0.170 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2022 | 295 | 0.170 |
Why?
|
HIV | 6 | 2024 | 1585 | 0.160 |
Why?
|
Chlamydia Infections | 1 | 2022 | 364 | 0.160 |
Why?
|
DNA, Mitochondrial | 1 | 2024 | 869 | 0.160 |
Why?
|
Humans | 67 | 2024 | 765823 | 0.160 |
Why?
|
Viremia | 2 | 2023 | 727 | 0.150 |
Why?
|
Interviews as Topic | 5 | 2010 | 2741 | 0.150 |
Why?
|
Gonorrhea | 1 | 2022 | 354 | 0.150 |
Why?
|
Firearms | 1 | 2006 | 630 | 0.150 |
Why?
|
Prospective Studies | 14 | 2024 | 54798 | 0.150 |
Why?
|
Alcohol Drinking | 3 | 2024 | 4041 | 0.150 |
Why?
|
Puerto Rico | 2 | 2016 | 380 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 531 | 0.140 |
Why?
|
Mothers | 5 | 2023 | 2207 | 0.140 |
Why?
|
Pyridones | 1 | 2022 | 816 | 0.140 |
Why?
|
Mental Health | 3 | 2024 | 3271 | 0.140 |
Why?
|
Medicaid | 1 | 2010 | 2832 | 0.130 |
Why?
|
Influenza Vaccines | 1 | 2024 | 780 | 0.130 |
Why?
|
Rhode Island | 2 | 2007 | 351 | 0.130 |
Why?
|
Child Behavior | 1 | 2021 | 864 | 0.120 |
Why?
|
Botswana | 1 | 2018 | 1057 | 0.120 |
Why?
|
Prevalence | 7 | 2024 | 15832 | 0.120 |
Why?
|
Male | 33 | 2024 | 363740 | 0.120 |
Why?
|
Adolescent Behavior | 2 | 2021 | 1185 | 0.120 |
Why?
|
Carnitine | 1 | 2016 | 254 | 0.120 |
Why?
|
Zimbabwe | 2 | 2012 | 135 | 0.110 |
Why?
|
Maternal Exposure | 3 | 2017 | 1096 | 0.110 |
Why?
|
Alu Elements | 1 | 2015 | 115 | 0.110 |
Why?
|
Infant | 10 | 2024 | 36375 | 0.110 |
Why?
|
Health Services | 1 | 2019 | 756 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1256 | 0.110 |
Why?
|
Fetus | 1 | 2021 | 1878 | 0.110 |
Why?
|
Telomere | 1 | 2019 | 941 | 0.110 |
Why?
|
Pregnancy Outcome | 1 | 2024 | 2968 | 0.110 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2015 | 332 | 0.100 |
Why?
|
Dangerous Behavior | 1 | 2012 | 65 | 0.100 |
Why?
|
Adenine | 2 | 2021 | 994 | 0.100 |
Why?
|
Depression | 2 | 2021 | 8224 | 0.100 |
Why?
|
Piperazines | 1 | 2022 | 2546 | 0.100 |
Why?
|
Vaccination | 1 | 2024 | 3425 | 0.100 |
Why?
|
South Africa | 3 | 2012 | 1868 | 0.090 |
Why?
|
Africa | 1 | 2013 | 725 | 0.090 |
Why?
|
Disclosure | 2 | 2023 | 756 | 0.090 |
Why?
|
Contraception Behavior | 2 | 2011 | 185 | 0.090 |
Why?
|
Risk-Taking | 2 | 2007 | 1021 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2235 | 0.080 |
Why?
|
Body Size | 1 | 2012 | 459 | 0.080 |
Why?
|
Birth Weight | 1 | 2017 | 2121 | 0.080 |
Why?
|
Research Design | 1 | 2024 | 6207 | 0.080 |
Why?
|
CD4 Lymphocyte Count | 3 | 2021 | 2586 | 0.080 |
Why?
|
Focus Groups | 2 | 2012 | 1459 | 0.070 |
Why?
|
Qualitative Research | 4 | 2012 | 3135 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2970 | 0.070 |
Why?
|
Wisconsin | 1 | 2007 | 121 | 0.070 |
Why?
|
Mississippi | 1 | 2007 | 93 | 0.070 |
Why?
|
Risk Factors | 12 | 2023 | 74853 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1194 | 0.070 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3815 | 0.060 |
Why?
|
Vitamin D | 1 | 2019 | 3272 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3834 | 0.060 |
Why?
|
Infant, Low Birth Weight | 3 | 2017 | 869 | 0.060 |
Why?
|
Social Adjustment | 1 | 2007 | 634 | 0.060 |
Why?
|
Parity | 2 | 2020 | 930 | 0.060 |
Why?
|
Health Behavior | 1 | 2016 | 2649 | 0.060 |
Why?
|
Crime | 1 | 2006 | 206 | 0.060 |
Why?
|
Self Report | 1 | 2016 | 3768 | 0.060 |
Why?
|
Patient Participation | 1 | 2013 | 1448 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 13466 | 0.060 |
Why?
|
Africa South of the Sahara | 2 | 2021 | 751 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9653 | 0.050 |
Why?
|
Choice Behavior | 1 | 2009 | 846 | 0.050 |
Why?
|
Logistic Models | 2 | 2016 | 13266 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2019 | 4528 | 0.050 |
Why?
|
California | 1 | 2007 | 1436 | 0.050 |
Why?
|
Attitude to Health | 1 | 2012 | 2019 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18380 | 0.050 |
Why?
|
Hepatitis B | 2 | 2005 | 708 | 0.050 |
Why?
|
Child, Preschool | 6 | 2024 | 42478 | 0.050 |
Why?
|
Bone Density | 1 | 2015 | 3490 | 0.050 |
Why?
|
Infant, Small for Gestational Age | 2 | 2017 | 468 | 0.050 |
Why?
|
Fertilization | 1 | 2023 | 197 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2010 | 12056 | 0.050 |
Why?
|
Weight Gain | 2 | 2022 | 2355 | 0.050 |
Why?
|
Patient Selection | 1 | 2013 | 4257 | 0.050 |
Why?
|
Chlamydia trachomatis | 1 | 2022 | 240 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2020 | 2532 | 0.040 |
Why?
|
Commerce | 1 | 2006 | 611 | 0.040 |
Why?
|
Ritonavir | 1 | 2022 | 330 | 0.040 |
Why?
|
DNA Methylation | 1 | 2015 | 4424 | 0.040 |
Why?
|
Africa, Southern | 2 | 2011 | 60 | 0.040 |
Why?
|
Neisseria gonorrhoeae | 1 | 2022 | 248 | 0.040 |
Why?
|
Pregnancy Trimesters | 1 | 2021 | 197 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2022 | 746 | 0.040 |
Why?
|
Quinolones | 1 | 2022 | 387 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2010 | 7840 | 0.040 |
Why?
|
RNA, Viral | 2 | 2019 | 2863 | 0.040 |
Why?
|
Interleukin-6 | 2 | 2023 | 3228 | 0.040 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 305 | 0.040 |
Why?
|
Parturition | 1 | 2022 | 453 | 0.040 |
Why?
|
Eicosanoids | 1 | 2019 | 284 | 0.040 |
Why?
|
Incidence | 4 | 2020 | 21501 | 0.030 |
Why?
|
Social Stigma | 1 | 2024 | 787 | 0.030 |
Why?
|
C-Reactive Protein | 2 | 2023 | 3851 | 0.030 |
Why?
|
Middle Aged | 8 | 2019 | 223016 | 0.030 |
Why?
|
Safe Sex | 2 | 2008 | 144 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 718 | 0.030 |
Why?
|
Cannabis | 1 | 2021 | 446 | 0.030 |
Why?
|
Gestational Age | 2 | 2015 | 3614 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1806 | 0.030 |
Why?
|
Hepatitis C | 1 | 2005 | 1596 | 0.030 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2019 | 597 | 0.030 |
Why?
|
Child Behavior Disorders | 1 | 2019 | 812 | 0.030 |
Why?
|
Alcoholism | 1 | 2004 | 1977 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2021 | 945 | 0.030 |
Why?
|
Refusal to Participate | 1 | 2013 | 30 | 0.030 |
Why?
|
Inflammation | 2 | 2023 | 10845 | 0.030 |
Why?
|
Influenza, Human | 1 | 2024 | 1539 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2019 | 1856 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26276 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 6304 | 0.020 |
Why?
|
Pregnancy Trimester, Third | 1 | 2015 | 587 | 0.020 |
Why?
|
Mood Disorders | 1 | 2019 | 1126 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39226 | 0.020 |
Why?
|
Lubricants | 1 | 2011 | 26 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2443 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2023 | 1946 | 0.020 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2013 | 427 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2716 | 0.020 |
Why?
|
Mother-Child Relations | 1 | 2015 | 499 | 0.020 |
Why?
|
Unsafe Sex | 1 | 2012 | 239 | 0.020 |
Why?
|
Body Height | 1 | 2017 | 1561 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2013 | 621 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2013 | 991 | 0.020 |
Why?
|
Counseling | 1 | 2016 | 1551 | 0.020 |
Why?
|
Coitus | 1 | 2008 | 133 | 0.020 |
Why?
|
Drug Resistance, Viral | 1 | 2012 | 866 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2739 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2511 | 0.020 |
Why?
|
Prenatal Care | 1 | 2015 | 1157 | 0.020 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2176 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22227 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40109 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4624 | 0.020 |
Why?
|
Population Surveillance | 1 | 2016 | 2595 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 13041 | 0.010 |
Why?
|
Mass Screening | 1 | 2020 | 5445 | 0.010 |
Why?
|
Age Distribution | 1 | 2009 | 2865 | 0.010 |
Why?
|
Alcoholic Beverages | 1 | 2004 | 265 | 0.010 |
Why?
|
Infant, Premature | 1 | 2012 | 2120 | 0.010 |
Why?
|
Cognition | 1 | 2020 | 7045 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7416 | 0.010 |
Why?
|
Cannabinoids | 1 | 2004 | 174 | 0.010 |
Why?
|
Aging | 1 | 2021 | 8731 | 0.010 |
Why?
|
Family Relations | 1 | 2003 | 318 | 0.010 |
Why?
|
Marijuana Abuse | 1 | 2004 | 410 | 0.010 |
Why?
|
Hypertension | 1 | 2020 | 8625 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10803 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 13078 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 30188 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10570 | 0.010 |
Why?
|
Attitude | 1 | 2003 | 769 | 0.010 |
Why?
|
Peer Group | 1 | 2003 | 703 | 0.010 |
Why?
|
Social Support | 1 | 2007 | 2191 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2007 | 2662 | 0.010 |
Why?
|
Health Surveys | 1 | 2003 | 4058 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 81505 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 8039 | 0.010 |
Why?
|
Health Personnel | 1 | 2003 | 3386 | 0.010 |
Why?
|
Aged | 1 | 2020 | 171178 | 0.000 |
Why?
|
Concepts
(229)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_